Grants per year
Personal profile
Training Experience
| 2003 | Residency, Royal College of Physicians, Ireland |
| 2009 | Fellowship, University of Texas Health Science Center, San Antonio |
| 2009 | Fellowship, Royal College of Physicians, Ireland |
Education/Academic qualification
PhD, National University of Ireland
… → 2009
MBBChBAO, National University of Ireland
… → 2000
Fingerprint
Dive into the research topics where Devalingam Mahalingam is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #DEK-DKK1-P205: A Phase 2a, Multicenter, Open-Label Study of DKN-01 in Combination with Tislelizumab ± Chemotherapy as First- Line or Second-Line Therapy in Adult Patients with Inoperable, Locally Advanced or Metastatic Gastric or Gastroesophageal Ju
Catalyst Clinical Research, LLC, Leap Therapeutics, Inc.
2/10/21 → 2/10/24
Project: Research project
-
Prot #Q702-ONC-P1-US001: A Phase 1, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacodynamic, Pharmacokinetic Study of Q702 with a Cohort Expansion at the RP2D in Patients with Advanced Solid Tumors
Translational Drug Development, LLC, Qurient Co. Ltd.
1/20/21 → 1/20/24
Project: Research project
-
Prot #EZH-108: A Phase 1, Open-Label Multi-Dose Two-Part Study to Characterize the Effects of a Strong CYP3A4 Inhibitor on the Steady-State Pharmacokinetics of Tazemetostat (EPZ-6438), And The Effects Of A Strong CYP3A4 Inducer on the Steady- State Pharma
Medpace Clinical Research LLC, Epizyme, Inc.
11/2/20 → 11/2/23
Project: Research project
-
Detection of hepatocellular carcinoma in a high-risk population by a mass spectrometry-based test
Mahalingam, D., Chelis, L., Nizamuddin, I., Lee, S. S., Kakolyris, S., Halff, G., Washburn, K., Attwood, K., Fahad, I., Grigorieva, J., Asmellash, S., Meyer, K., Oliveira, C., Roder, H., Roder, J. & Iyer, R., Jul 1 2021, In: Cancers. 13, 13, 3109.Research output: Contribution to journal › Article › peer-review
Open Access -
Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response
De Souza, A., Tavora, F. A., Mahalingam, D., Munster, P. N., Safran, H. P., El-Deiry, W. S. & Carneiro, B. A., Oct 19 2020, In: Frontiers in immunology. 11, 595289.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Scopus citations -
Correction to: Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and Validation (CardioVascular and Interventional Radiology, (2019), 42, 5, (700-711), 10.1007/s00270-019-02191-z)
Ali, R., Yang, Y., Antkowiak, M., Gabr, A., Mora, R., Abouchaleh, N., Asadi, A. A., Kulik, L., Ganger, D., Abecassis, M., Katariya, N., Mulcahy, M., Benson, A., Mahalingam, D., Thornburg, B., Mouli, S., Lewandowski, R. J., Salem, R. & Riaz, A., May 1 2020, In: Cardiovascular and Interventional Radiology. 43, 5, p. 806 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Pembrolizumab in combination with the oncolytic virus pelareorep and chemotherapy in patients with advanced pancreatic adenocarcinoma: A phase Ib study a C
Mahalingam, D., Wilkinson, G. A., Eng, K. H., Fields, P., Raber, P., Moseley, J. L., Cheetham, K., Coffey, M., Nuovo, G., Kalinski, P., Zhang, B., Arora, S. P. & Fountzilas, C., Jan 1 2020, In: Clinical Cancer Research. 26, 1, p. 71-81 11 p.Research output: Contribution to journal › Article › peer-review
Open Access32 Scopus citations -
Phase I and biomarker study of the wnt pathway modulator dkn-01 in combination with gemcitabine/ cisplatin in advanced biliary tract cancer
Goyal, L., Sirard, C., Schrag, M., Kagey, M. H., Eads, J. R., Stein, S., El-Khoueiry, A. B., Manji, G. A., Abrams, T. A., Khorana, A. A., Miksad, R., Mahalingam, D., Zhu, A. X. & Duda, D. G., Dec 2020, In: Clinical Cancer Research. 26, 23, p. 6158-6167 10 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations